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Purpose: The aim of this study was to evaluate the safety and accuracy of a new portable 
ultrasonography-guided high-intensity focused ultrasound (USg-HIFU) system with a 
3-dimensional (3D) electronic steering transducer, a simultaneous ablation and imaging module, 
real-time cavitation monitoring, and 3D image reconstruction algorithms. 
Methods: To address the accuracy of the transducer, hydrophones in a water chamber were 
used to assess the generation of sonic fields. An animal study was also performed in five pigs 
by ablating in vivo thighs by single-point sonication (n=10) or volume sonication (n=10) and 
ex vivo kidneys by single-point sonication (n=10). Histological and statistical analyses were 
performed. 
Results: In the hydrophone study, peak voltages were detected within 1.0 mm from the targets 
on the y- and z-axes and within 2.0-mm intervals along the x-axis (z-axis, direction of ultrasound 
propagation; y- and x-axes, perpendicular to the direction of ultrasound propagation). Twenty-
nine of 30 HIFU sessions successfully created ablations at the target. The in vivo porcine thigh 
study showed only a small discrepancy (width, 0.5-1.1 mm; length, 3.0 mm) between the 
planning ultrasonograms and the pathological specimens. Inordinate thermal damage was 
not observed in the adjacent tissues or sonic pathways in the in vivo thigh and ex vivo kidney 
studies. 
Conclusion: Our study suggests that this new USg-HIFU system may be a safe and accurate 
technique for ablating soft tissues and encapsulated organs. 
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Introduction
High-intensity focused ultrasound (HIFU) is a promising technology 
that has shown promising results in diverse clinical and preclinical 
studies [1-6]. This technique has attracted special attention not 
only as a tumor ablation method but also as a gene delivery, drug 
delivery, and immunotherapy modality [7,8]. 
In an effort to improve treatment efficacy and safety, current 
HIFU machines are operated in combination with a few different 
image-guiding systems. Therefore, on the basis of the combined 
imaging modalities, the HIFU system can be divided into magnetic 
resonance-guided HIFU (MRg-HIFU) and ultrasonography-guided 
HIFU (USg-HIFU) [1]. In particular, MRg-HIFU is advantageous for 
identifying the target and adjacent structures with a high contrast 
resolution and to monitor the temperature with magnetic resonance 
(MR) thermometry techniques, which makes the system feasible for 
treating uterine fibroids and various brain diseases in real clinical 
practice [1,9-11]. In contrast, USg-HIFU has potential strengths 
in the “real-time” monitoring of the targets in terms of acoustic 
cavitation, as well as structural changes [12-14]. These potential 
advantages may be particularly beneficial to the ablation of moving 
structures such as the liver and kidneys, compared with the MRg-
HIFU system. In addition, ideally, USg-HIFU can provide operators 
with more flexibility because it does not require a large gantry, 
which is indispensable in MRg-HIFU [3].
Despite the aforementioned potential strengths, unfortunately, 
USg-HIFU has not been widely used in clinical practice mainly 
because the potential strengths of USg-HIFU have not been 
actualized sufficiently to overcome its weaknesses of providing less 
accuracy in planning and post-ablation assessment, compared with 
MRg-HIFU [3,15]. However, with recent advances in ultrasound 
(US) transducers and image processing techniques, many trials to 
maximize the strengths and minimize the weaknesses of USg-HIFU 
are being performed on an ongoing basis, for instance, by adopting 
3-dimensional (3D) electronic steering transducers and real-time 3D 
ultrasonography [1,16,17]. In addition, new USg-HIFU systems allow 
portability in adopting compact HIFU devices with high-powered 
equipment. Furthermore, a diagnostic ultrasonography system and 
HIFU are synchronized, which provides real-time ultrasonography 
during ablation without the interference phenomenon [18,19].
Considering the above-mentioned advances in US technologies, 
we believe that the strengths of up-to-date USg-HIFU are worth 
revisiting. Therefore, we conducted a hydrophone study and 
preclinical in vivo and ex vivo studies to address the safety and 
accuracy of a new portable USg-HIFU unit equipped with a 
3D electronic steering transducer, a simultaneous ablation and 
imaging module, real-time cavitation monitoring, and 3D image 
reconstruction algorithms.
Materials and Methods
The investigational HIFU system for this study was provided by 
Alpinion Medical Systems (Seoul, Korea). The authors had complete 
control of the experimental data, which were unbiased by the 
industry.
Animals
This study was approved by our Institutional Animal Care and Use 
Committee (IACUC protocol number 13-0001), and performed in 
accordance with the institutional guidelines. Five male pigs that 
weighed 50-60 kg were used in our study. For the in vivo study, 
the pigs were starved 12 hours prior to the HIFU ablation. Each 
animal was sedated with an intramuscular injection of zolazepam 
(5 mg/kg, Zoletil; Virbac, Carroscedex, France) and xylazine (10 mg/
kg, Rompun; Bayer-Schering Pharma, Berlin, Germany), and the 
animals were then intubated and ventilated during the procedures. 
Anesthesia was maintained by the inhalation of 1%-3% isoflurane 
in pure oxygen gas. To facilitate US propagation through the skin, 
the pigs underwent the shaving and subsequent waxing of their 
bilateral thighs and flanks prior to the procedures. During the entire 
HIFU procedures, the animals’ vital signs, including pulse rate, 
electrocardiogram, and temperatures, were carefully monitored. 
USg-HIFU System
The USg-HIFU device (ALPIUS; Alpinion Medical Systems, Seoul, 
Korea) used in our study is 1.8 m, 1.2 m, and 1.6 m in length, width, 
and height, respectively (Fig. 1). The four wheels installed under the 
Fig. 1. A photograph showing the ultrasonography-guided high-
intensity focused ultrasound (HIFU) system used in this study.
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main body make the device portable. The system includes an HIFU 
transducer with a focal length of 9 cm driven at its fundamental 
frequency of 1 MHz. This system had a phased-array 256-channel 
transducer (radius of curvature, 9 cm; aperture size, 15 cm), which 
has a steering range along the z-axis of 40 mm and along the x- and 
y-axes of 24 mm (z-axis, direction of US propagation; y- and x-axes, 
perpendicular to the direction of US propagation). Therefore, the 
system can perform volumetric ablation by electronically steering the 
focal spots in a 3D space, without repositioning the transducer. The 
natural focal size of the transducer is 1.5 mm×1.5 mm×8 mm at -6 
dB. The ultrasonic power measured using a radiation-force balance 
system varies from 1 W to 1 kW. During ablation, the transducer can 
be cooled using degassed water at 9°C-15°C.
In terms of the imaging guidance, a 3.5-MHz ultrasonography 
transducer is placed at the center of the HIFU transducer for the 
planning and treatment monitoring. As the image transducer rotates, 
it provides the 3D volume data reconstructed from 2D images, which 
can be used for ablation planning. During the procedure, ablation 
was supervised through the interleaving/synchronization control 
between the HIFU ablation and the imaging modules. In addition, 
this system has four passive cavitation detection (PCD) sensors 
installed on the US radiation surface of the HIFU transducer. During 
the procedure, the occurrence of excessive microbubbles can be 
monitored by a preinstalled system that archives the acoustic signals 
obtained from the PCD sensors [20-22].
Accuracy Study of Acoustic Steering Using Hydrophones
To address the targeting accuracy of the transducer, hydrophones 
(AST3-L; ONDA Co., Sunnyvale, CA, USA) in a water chamber 
assessed the sonic field generation during HIFU ablation (Fig. 2). On 
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Fig. 2. An ex vivo study to evaluate the accuracy of our 
transducer. AIMS, acoustic intensity measurement system; EMDS-
USB, electronic motor drive system-universal serial bus.
A. Schematic representation depicting the phased array transducer 
(high-intensity focused ultrasound source) and a hydrophone fixed in 
a water chamber, which archived the peak voltages in the x-, y-, and 
z-coordinates. B, C. Plots showing the peak voltage measurements 
in the axial (z-axis) and lateral (x-axis) coordinates.
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the premise that the trajectory of sonication in the neutral status is 
along the z-axis, 10-mm beam steering on the x- and y-axes (with 
targets having depths of 70 mm, 90 mm, and 110 mm) was tested, 
using the phased-array HIFU transducer. In particular, 15 imaginary 
targets with different x-, y-, and z-coordinates were aimed: (0, 0, 
70), (-10, 0, 70), (10, 0, 70), (0, -10, 70), (0, 10, 70), (0, 0, 90), 
(-10, 0, 90), (10, 0, 90), (0, -10, 90), (0, 10, 90), (0, 0, 110), (-10, 
0, 110), (10, 0, 110), (0, -10, 110), and (0, 10, 110). The phased-
array transducer, fixed in the water chamber, changed the x- and 
y-axes using beam steering. After each experiment, the x-, y-, and 
z-coordinates of the peak voltage (recorded in the hydrophones) 
were archived to evaluate the transducer accuracy. The peak voltage 
was measured five times for each target point.
Animal Study
The animal studies were performed with in vivo thighs and ex vivo 
kidneys of five pigs. On the HIFU bed, volumetric ultrasonograms 
were obtained using an imaging transducer embedded in the HIFU 
machine for planning the ablation. Based on the 3D plan and preset 
protocols, the pigs were extracorporeally ablated for the imaginary 
targets, with two “single-point sonication” modes in the left thigh 
and two “volume sonication” modes in the right thigh (Table 1). 
During the procedures, echogenic changes in the target and the 
occurrence of excessive acoustic cavitation were monitored in real-
time. If inordinate cavitation was detected during the procedure, the 
ablation was discontinued to minimize adverse effects. The animals 
were euthanized within 3 hours after the procedure by using an 
intravenous injection of potassium chloride (2 ampoules/pig, 20 mL/
ampoule, JW Pharmaceutical, Seoul, Korea), and their thighs were 
sampled for the histological analyses.
Subsequently, studies using explants were conducted to evaluate 
the safety of HIFU ablation in a deep-seated, encapsulated organ, 
overlaid by other tissues with various sonic interfaces. After 
euthanasia of the animals, the pigs’ kidneys along with adjacent 
retroperitoneal fat tissues, abdominal wall muscles, subcutaneous 
tissues, and skin were isolated. A thin-wire thermocouple (75 µm, 
Omega Engineering, Stamford, CT, USA) was inserted in either end 
of the kidney, away from the ablation zone, to monitor the potential 
thermal effect of the untargeted area in the kidney. Afterwards, 
the kidneys were immobilized on a gel pad in a container located 
at the center of a degassed water tank, and all the samples were 
maintained at 35°C-37°C during the entire experiment, to simulate 
the intra-abdominal conditions (Fig. 3). The HIFU procedure was 
conducted to ablate the renal parenchyma under the guidance of 
ultrasonography (Table 1).
Histological Analysis
Prior to tissue preparation, changes in the skin, if any, were inspected 
to detect undesirable skin damage. The thigh specimens, including 
the entire muscle layer and the overlying skin and subcutaneous fat 
tissues combined were sampled to be 22 cm×18 cm in area and 
8 cm in thickness. The tissue blocks were immediately immersed 
in 1.5 L of normal saline at 4°C. To fix the specimens, three serial 
Fig. 3. Schematic representation of the experiment using isolated 
kidney samples. HIFU, high-intensity focused ultrasound.
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Table 1. High-intensity focused ultrasound ablation parameters considered in our study
Mode
Acoustic power 
(W)
No. of ablation 
points
Exposure time 
per point (sec)
Duty cycle (%)
Inter-point 
movement time 
(sec)
Total procedure 
time (sec)
Target depth 
from the skin 
(mm)
In vivo study (thigh muscles)
   Single-point sonication 80 7 4 80 0.5 31 30
96 7 4 80 0.5 31 30
   Volume sonication 80 19 4 80 0.5 85 40
72 37 4 80 0.5 166 40
Ex vivo study (kidneys)
   Single-point sonication 150 7 10 80 0.5 73 30New portable HIFU: a preclinical study in pigs
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sections (dimensions of each section: 22 cm×6 cm×8 cm) parallel 
to the axis of the sonic pathway were obtained and embedded in 
10% buffered formalin for 4 days. Subsequently, serial sections 
parallel to the previous section having a thickness of 4 mm were 
acquired from the fixed tissues. From these specimens, undesirable 
thermal damage in the sonic pathways and the size of the ablation 
zone were evaluated. For further evaluation, the target lesions and 
the surrounding healthy tissues were sampled; they had a thickness 
of 4 μm and were stained with hematoxylin-eosin-saffron. The 
kidney specimens were prepared in the same manner and were 
serially sliced to have a thickness of 4 mm. From these specimens, 
undesirable thermal damage in the sonic pathways was evaluated.
Statistical Analysis
The discrepancy in the ablation sizes on the planning US images 
and gross specimens were evaluated using the Bland-Altman 
method [23]. A P-value of less than 0.05 was determined to indicate 
statistical significance. Statistical analyses were performed using 
MedCalc ver. 12.7 (MedCalc Software, Ostend, Belgium).
Results
According to the accuracy study of acoustic steering using 
hydrophones, peak voltages were detected within 1.0 mm of the 
imaginary targets on the y- and z-axes, and within 2.0-mm intervals 
along the x-axis, for all targets (Fig. 2).
In the porcine study, 29 of 30 HIFU sessions (96.7%), including 
19 targets in in vivo thighs and 10 targets in ex vivo kidneys, 
successfully created ablation zones. In the remaining HIFU session 
targeting the thigh, excessive acoustic cavitation was observed 
in real-time; therefore, the procedure was terminated earlier than 
originally planned. In this session, B-mode ultrasonography also 
demonstrated diffuse hyperechoic changes in and around the target. 
Therefore, this case was used only for safety evaluations and was 
excluded from the accuracy analyses.
In terms of safety, ultrasonograms acquired simultaneously during 
each HIFU session demonstrated that ablation occurred according to 
the plans drawn on the 3D ultrasonograms. Concordantly, gross and 
histological examinations revealed that none of the 30 specimens, 
including both thighs and kidneys, received inordinate tissue injury 
in the sonic pathways. In the kidney studies, interfaces between 
different tissues were also intact in all specimens. According to the 
histological analyses, healthy tissues beyond the target demonstrated 
normal structures, in contrast with disrupted architecture in the 
targets (Fig. 4). In addition, there was a temperature increase of less 
than 2°C in all kidneys.
With respect to the accuracy of the in vivo study, variable targets 
6.0-11.0 mm in depth (z-axis) and 7.0-8.0 mm in width (x- and 
y-axes) were aimed with single-point sonication modes (80 W, 96 W). 
Consequently, ablation volumes were created with a length of 9.8-
13.6 mm and a width of 4.9-7.7 mm (Table 2). With respect to the 
volume sonication modes (72 W, 80 W), the targets were planned 
to be 13.8-22.0 mm in length and 13.9-19.8 mm in width. As 
a result, ablation volumes with a length of 14.0-28.9 mm and a 
width of 9.5-24.0 mm were obtained (Table 2).
According to the Bland-Altman plots, the actual ablation volume 
Fig. 4. Histological specimens of the in vivo study targeting the thigh muscles of a pig. 
A. Photograph showing two ablated targets (arrows) formed by the volume sonication mode in the thigh muscle. B. Microscopic image 
(hemotoxylin-eosin-saffron staining, ×12.5) showing normal area on the left, ablated area on the right, and transitional zone in the middle.
A BJin Woo Choi, et al.
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ultrasonograms (Fig. 6). 
Discussion
This new portable USg-HIFU system equipped with a state-of-
in the single-point sonication mode was 3.0±4.5 mm (mean±SD) 
larger in length and 1.1±1.9 mm smaller in width than that of 
the preprocedural planning (Fig. 5). The actual ablation achieved 
in the volume sonication mode was 3.0±1.6 mm larger in length 
and 0.5±8.8 mm smaller in width, compared with the planning 
Fig. 6. Bland-Altman plots showing the accuracy of the volume sonication mode. The pink and orange lines denote the regression line 
and its 95% confidence interval US, ultrasonography.
A. In terms of the length, the histological specimens reveal a 3.0±1.6 mm (mean±SD) larger ablation zone than the planning 
ultrasonograms. There is a slight tendency for shallower targets (smaller depths) to create larger discrepancies along the z-axis. B. In terms of 
the width, the histological specimens reveal a 0.5±8.8 mm smaller ablation zone than the planning images.
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A. In terms of the length, the histological specimens reveal a 3.0±4.5 mm (mean±SD) larger ablation zone than the planning ultrasonograms. 
There is a slight tendency for the shallower targets (smaller depths) to create larger discrepancies along the z-axis. B. In terms of the width, 
the histological specimens reveal a 1.1±1.9 mm smaller ablation zone than the planning images.
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the art transducer enabling 3D electronic steering and real-time 
cavitation monitoring and a 3D reconstruction imaging algorithm 
demonstrated high safety and high accuracy, that is, close similarity 
between the planning and the real ablated lesions. Compared with 
an MRg-HIFU study with a similar experimental design [9], the 
small discrepancy (mean width, 0.5-1.1 mm; mean length, 3.0 
mm) between the planning ultrasonograms and the pathological 
specimens in our study suggests at least a comparable accuracy 
between the MRg-HIFU and the USg-HIFU systems. The high 
accuracy of this USg-HIFU system might stem from the precise 
preprocedural planning of the 3D images and the excellent control 
unit, which facilitated accurate predictions of the created ablation 
size. The 3D images can compensate for an erroneous perception 
of the target (depending on the position of the transducer and the 
target) and may provide objective and reproducible volume data to 
the operators. For these reasons, this image reconstruction technique 
has already been widely used in various clinical fields [24,25]. 
This USg-HIFU system demonstrated satisfactory safety in that 
none of the 30 specimens received inordinate tissue injury in the 
sonic pathways. In contrast with MRg-HIFU, USg-HIFU can reveal 
real-time structural changes in the target and real-time spatial 
relationships between the targets and the transducers in the sonic 
pathway. Furthermore, recently developed algorithms facilitate a 
reliable assessment of real-time cavitation creation during ablation 
[20-22]. These methods are helpful in determining the optimal 
projection and in avoiding potentially dangerous sonication. 
Concordantly, our results showed precise ablation of the targets 
without any unintended tissue damage. In particular, the real-
time cavitation monitoring system allowed early termination of a 
case that was considered excessively damaged. Our results also 
demonstrate that this USg-HIFU technique may be safe for ablating 
deep-seated, encapsulated organs such as the kidneys. Because 
many ablative targets such as uterine fibroids, renal cell carcinomas, 
and liver tumors are deep-seated and located within encapsulated 
organs, these results suggest the clinical applicability of our USg-
HIFU system.
Moreover, the portability of our device may provide new clinical 
applications. Compared with many current USg-HIFU and MRg-HIFU 
devices fixed in a dedicated room, this USg-HIFU system can be 
moved to and installed at the bedside. In other words, this system 
may yield superior comfort for patients, provide operators greater 
accessibility to patients, and make better use of hospital space. 
Furthermore, given that the MRg-HIFU system limits the use of 
many metallic medical devices in the operating room, the USg-HIFU 
system appears to offer greater flexibility for combination with other 
medical procedures or advanced monitoring equipment.
There are a few limitations to our study. First, we were unable 
to directly compare the performance of this USg-HIFU with that of 
MRg-HIFU. However, the high accuracy of this USg-HIFU system 
appears to be acceptable to clinicians. Furthermore, our results are 
apparently comparable with those of a MRg-HIFU study with a 
similar experimental design [9]. Second, the sample size in our study 
is quite small. However, we utilized the 5 animals using various 
methods and were thus able to conduct 30 ablation sessions. 
Considering that this investigation was a preclinical feasibility study, 
our study design appears to be acceptable with respect to scientific 
rigor and animal welfare. Third, we did not identify the therapeutic 
effect of our system on mobile structures such as the liver. However, 
it is expected that this USg-HIFU system, which showed excellent 
accuracy in static tissues, may be applicable to mobile organs, along 
with adequate gating and monitoring systems. Fourth, the accuracy 
of targeting the sonication spot was not evaluated. Since the 
accurate localization of the target is critical for safe HIFU treatments, 
it should be fully evaluated in future studies. Additionally, in vivo 
Table 2. Comparison of the ablation size estimated on the 
planning ultrasonograms and specimens
Mode Pig ID
Size in the 
ultrasonograms (A)
Size on gross 
pathology (B)
Length 
(mm)
Width 
(mm)
Length 
(mm)
Width 
(mm)
Single-point 
sonication 
(80 W)
1 8.0 7.4 10.7 7.3
2 7.0 7.3 12.4 5.5
3 7.0 7.3 13.6 7.7
4 6.0 7.0 10.9 6.4
5 8.0 7.4 11.4 4.9
Single-point 
sonication 
(96 W)
1
a) - - - -
2 10.5 8.0 9.8 6.2
3 9.5 7.6 11.1 7.3
4 8.5 7.5 10.9 6.5
5 11.0 7.8 12.1 6.0
Volume 
sonication 
(72 W)
1 19.0 19.8 28.9 19.6
2 16.5 19.3 18.8 9.5
3 21.0 19.8 17.9 18.1
4 22.0 19.8 22.3 19.4
5 18.5 19.8 21.3 24.0
Volume 
sonication 
(80 W)
1 15.4 13.9 14.0 11.4
2 13.8 13.9 19.6 12.6
3 18.2 14.4 20.4 11.3
4 15.4 13.9 21.3 17.8
5 17.2 14.0 22.1 20.0
a) These data were excluded from analysis because the high-intensity focused 
ultrasound was terminated early, based on the results of the acoustic cavitation 
monitoring.Jin Woo Choi, et al.
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kidney experiments should be conducted in the next step to evaluate 
the suitability of this USg-HIFU system for safe HIFU treatment.
In conclusion, this study demonstrated the high safety and 
accuracy of a new USg-HIFU system that was equipped with 
a compact and high-powered electronic steering transducer, a 
simultaneous ablation and imaging module, and real-time cavitation 
monitoring under the guidance of a 3D, real-time, and portable 
ultrasonography device. Compared with the MRg-HIFU, this USg-
HIFU system might provide more flexibility and comparable accuracy 
and safety in many applications.
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